AnaCardio

AnaCardio

Signal active

Organization

Contact Information

Overview

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

About

Industries

Biotechnology, Medical, Biopharma

Founded

2017

Employees

1-10

Headquarters locations

Solna, Stockholms Lan, Sweden, Europe

Social

Profile Resume

AnaCardio headquartered in Europe, operates in the Biotechnology, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $635.0M in funding across 36 round(s). With a team of 1-10 employees, AnaCardio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - AnaCardio, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

3

Investors

1

Lead Investors

0

Total Funding Amount

$17.6M

Details

2

AnaCardio has raised a total of $17.6M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2022Early Stage Venture14.0M
2021Seed

Investors

AnaCardio is funded by 15 investors.

Investor NameLead InvestorFunding RoundPartners
AnnHelene Ljungström-FUNDING ROUND - AnnHelene Ljungström3.6M
Viktor Drvota-FUNDING ROUND - Viktor Drvotaundefined
AnaCardio-FUNDING ROUND - AnaCardioundefined
Karolinska-FUNDING ROUND - Karolinskaundefined